132 related articles for article (PubMed ID: 29731825)
1. MicroRNA-27a participates in the pathological process of depression in rats by regulating VEGFA.
Cui J; Gong C; Cao B; Li L
Exp Ther Med; 2018 May; 15(5):4349-4355. PubMed ID: 29731825
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-27a-3p Downregulation Inhibits Inflammatory Response and Hippocampal Neuronal Cell Apoptosis by Upregulating Mitogen-Activated Protein Kinase 4 (MAP2K4) Expression in Epilepsy: In Vivo and In Vitro Studies.
Lu J; Zhou N; Yang P; Deng L; Liu G
Med Sci Monit; 2019 Nov; 25():8499-8508. PubMed ID: 31710596
[TBL] [Abstract][Full Text] [Related]
3. Upregulated miR-27a-3p Indicates a Poor Prognosis in Pancreatic Carcinoma Patients and Promotes the Angiogenesis and Migration by Epigenetic Silencing of GATA6 and Activating VEGFA/VEGFR2 Signaling Pathway.
Rao X; Wan L; Jie Z; Zhu X; Yin J; Cao H
Onco Targets Ther; 2019; 12():11241-11254. PubMed ID: 31908490
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-30b participates in the pathological process of hyperuricemia by regulating interleukin-6 receptor.
Zhong X; Chen Y; Yao C; Xu L; Peng Y; Yang Q; Zhao M; Guo X
Nucleosides Nucleotides Nucleic Acids; 2020; 39(8):1162-1178. PubMed ID: 32643523
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of microRNA-17 in hippocampal tissues and blood from mice with depression up-regulates the expression of PAI-1 mRNA and protein.
Lv M; Li J; Gao X; Hao Y; Zhao F
Braz J Med Biol Res; 2020; 53(10):e8826. PubMed ID: 32901686
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-27a Suppresses Detrusor Fibrosis in Streptozotocin-Induced Diabetic Rats by Targeting PRKAA2 Through the TGF-β1/Smad3 Signaling Pathway.
Wu J; Liu S; Yuan ZW; Liu JH; Li JM; Chen T; Fang KW
Cell Physiol Biochem; 2018; 45(4):1333-1349. PubMed ID: 29462799
[TBL] [Abstract][Full Text] [Related]
7. MiRNA-27a promotes the proliferation and invasion of human gastric cancer MGC803 cells by targeting
Wu F; Li J; Guo N; Wang XH; Liao YQ
Am J Cancer Res; 2017; 7(3):405-416. PubMed ID: 28401000
[TBL] [Abstract][Full Text] [Related]
8. miR‑140‑5p regulates angiogenesis following ischemic stroke by targeting VEGFA.
Sun J; Tao S; Liu L; Guo D; Xia Z; Huang M
Mol Med Rep; 2016 May; 13(5):4499-505. PubMed ID: 27035554
[TBL] [Abstract][Full Text] [Related]
9. Expression and role of VEGFA and miR-381 in portal vein tumor thrombi in patients with hepatocellular carcinoma.
Wang J; Wu S; Huang T
Exp Ther Med; 2018 Jun; 15(6):5450-5456. PubMed ID: 29904424
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-27a-3p suppression of peroxisome proliferator-activated receptor-γ contributes to cognitive impairments resulting from sevoflurane treatment.
Lv X; Yan J; Jiang J; Zhou X; Lu Y; Jiang H
J Neurochem; 2017 Nov; 143(3):306-319. PubMed ID: 28881034
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of miR-27a against traumatic brain injury via suppressing FoxO3a-mediated neuronal autophagy.
Sun L; Zhao M; Wang Y; Liu A; Lv M; Li Y; Yang X; Wu Z
Biochem Biophys Res Commun; 2017 Jan; 482(4):1141-1147. PubMed ID: 27919684
[TBL] [Abstract][Full Text] [Related]
13. MiR-27a ameliorates inflammatory damage to the blood-spinal cord barrier after spinal cord ischemia: reperfusion injury in rats by downregulating TICAM-2 of the TLR4 signaling pathway.
Li XQ; Lv HW; Wang ZL; Tan WF; Fang B; Ma H
J Neuroinflammation; 2015 Feb; 12():25. PubMed ID: 25876455
[TBL] [Abstract][Full Text] [Related]
14. MiR-27a promotes hepatocellular carcinoma cell proliferation through suppression of its target gene peroxisome proliferator-activated receptor γ.
Li S; Li J; Fei BY; Shao D; Pan Y; Mo ZH; Sun BZ; Zhang D; Zheng X; Zhang M; Zhang XW; Chen L
Chin Med J (Engl); 2015 Apr; 128(7):941-7. PubMed ID: 25836616
[TBL] [Abstract][Full Text] [Related]
15. MiR-27a promotes EMT in ovarian cancer through active Wnt/𝜷-catenin signalling by targeting FOXO1.
Zhang LY; Chen Y; Jia J; Zhu X; He Y; Wu LM
Cancer Biomark; 2019; 24(1):31-42. PubMed ID: 30614794
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of miR-27a suppresses the inflammatory response via the p38/MAPK pathway in intervertebral disc cells.
Cao Z; Chen L
Exp Ther Med; 2017 Nov; 14(5):4572-4578. PubMed ID: 29067127
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-27a functions as an oncogene in human osteosarcoma by targeting CCNG1.
Lin T; Ma Q; Zhang Y; Zhang H; Yan J; Gao C
Oncol Lett; 2018 Jan; 15(1):1067-1071. PubMed ID: 29399167
[TBL] [Abstract][Full Text] [Related]
18. Emerging role of microRNA-27a in human malignant glioma cell survival via targeting of prohibitin.
Chen W; Qi J; Bao G; Wang T; Du CW; Wang MD
Mol Med Rep; 2015 Jul; 12(1):1515-23. PubMed ID: 25777779
[TBL] [Abstract][Full Text] [Related]
19. miR-27a-mediated antiproliferative effects of metformin on the breast cancer cell line MCF-7.
Zhao W; Zhang X; Liu J; Sun B; Tang H; Zhang H
Oncol Rep; 2016 Dec; 36(6):3691-3699. PubMed ID: 27779715
[TBL] [Abstract][Full Text] [Related]
20. The protective effect of MiR-27a on the neonatal hypoxic-ischemic encephalopathy by targeting FOXO1 in rats.
Cai Q; Zhang X; Shen L; Song H; Wang T
Transl Pediatr; 2022 Jul; 11(7):1199-1208. PubMed ID: 35958013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
